A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 2, 2009, Pages 71-77

  Badorrek, Philipp ^a   Dick, M ^a   Schauerte, A ^a   Hecker, H ^b   Murdoch, R ^c   Luettig, B ^a   Hohlfeld, J M ^a   Krug, N ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antihistamine; Decongestant; Environmental challenge chamber; Intermittent allergic rhinitis; Nasal symptom score

Indexed keywords

ALLERGEN; CETIRIZINE; PLACEBO; PSEUDOEPHEDRINE; DECONGESTIVE AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST;

ABDOMINAL CRAMP; ADULT; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG WITHDRAWAL; EFFECT SIZE; ENVIRONMENTAL EXPOSURE; FEMALE; GRASS POLLEN; HAY FEVER; HEART PALPITATION; HOT FLUSH; HUMAN; MALE; NOSE OBSTRUCTION; NOSE SECRETION; PHOTOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SCORING SYSTEM; SKIN TEST; SOMNOLENCE; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VISUAL ANALOG SCALE; XEROSTOMIA; DRUG COMBINATION; DRUG POTENTIATION; IMMUNOLOGY; MIDDLE AGED; POLLEN;

ADULT; CETIRIZINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG SYNERGISM; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; MIDDLE AGED; NASAL DECONGESTANTS; NASAL OBSTRUCTION; POLLEN; PSEUDOEPHEDRINE; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 62749130624     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47071     Document Type: Article

References (11)

1. Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicenter study. Rhinology. 1996; 34: 91-96.
2. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001; 108 (Suppl 5): S147-334.
3. Bousquet J. Allergic rhinitis and its impact on asthma - executive summary. Allergy. 2002; 57: 841-855.
4. Bousquet J. Antihistamines in severe/chronic rhinitis. Clin Exp Allergy. 1998; 28 (Suppl. 6): 49-53.
5. Bousquet J. Visual analog scale can assess the severity of rhinitis graded according to ARAIguidelines. Allergy. 2007; 62: 367-372.
6. Grosclaude M, Mees K, Pinelli ME, Lucas M, Van de Venne H. Cetirizine and pseudoephedine retard, given alone or in combination, in patients with seasonal allergic rhinitis. Rhinology. 1997; 35: 67-73.
7. Horak F, Toth J, Marks B, Stübner UP, Berger UE, Jäger S, Burtin B, Duby C. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion. Allergy. 1998; 53: 849-856.
8. Krug N, Hohlfeld JM, Larbig M, Buckendahl A, Badorrok P, Geldmacher H, Behnke W, Dunkhorst W, Windt H, Luettig B, Koch W. Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis. Clin Exp Allergy. 2003; 33: 1667-1674.
9. Stübner UP, Toth J, Marks B, Berger UE, Burtin B, Horak F. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion. Arzneimittelforschung. 2001; 11: 904-910.
10. Wellington K, Jarvis B. Cetirizine/Pseudoephedrine. Drugs. 2001; 61: 2231-2239.
11. Zieglmayer UP, Horak F, Toth, Marks B, Berger UE, Burtin B. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis. Treat Respir Med. 2005; 4: 283-287.